Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective
- PMID: 31180143
- PMCID: PMC9495288
- DOI: 10.1111/nyas.14129
Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective
Abstract
Microorganisms resident in our bodies participate in a variety of regulatory and pathogenic processes. Here, we describe how etiological pathways implicated in Alzheimer's disease (AD) may be regulated or disturbed by symbiotic microbial activity. Furthermore, the composition of symbiotic microbes has changed dramatically across human history alongside the rise of agriculturalism, industrialization, and globalization. We postulate that each of these lifestyle transitions engendered progressive depletion of microbial diversity and enhancement of virulence, thereby enhancing AD risk pathways. It is likely that the human life span extended into the eighth decade tens of thousands of years ago, yet little is known about premodern geriatric epidemiology. We propose that microbiota of the gut, oral cavity, nasal cavity, and brain may modulate AD pathogenesis, and that changes in the microbial composition of these body regions across history suggest escalation of AD risk. Dysbiosis may promote immunoregulatory dysfunction due to inadequate education of the immune system, chronic inflammation, and epithelial barrier permeability. Subsequently, proinflammatory agents-and occasionally microbes-may infiltrate the brain and promote AD pathogenic processes. APOE genotypes appear to moderate the effect of dysbiosis on AD risk. Elucidating the effect of symbiotic microbiota on AD pathogenesis could contribute to basic and translational research.
Keywords: Alzheimer's disease; dementia; evolutionary medicine; immunoregulation; microbiome.
© 2019 New York Academy of Sciences.
Conflict of interest statement
Competing interests
The authors declare no competing interests.
Figures


Similar articles
-
Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.Nutrients. 2021 Feb 21;13(2):690. doi: 10.3390/nu13020690. Nutrients. 2021. PMID: 33669988 Free PMC article. Review.
-
Interlink between the gut microbiota and inflammation in the context of oxidative stress in Alzheimer's disease progression.Gut Microbes. 2023 Jan-Dec;15(1):2206504. doi: 10.1080/19490976.2023.2206504. Gut Microbes. 2023. PMID: 37127846 Free PMC article. Review.
-
Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.Life Sci. 2021 Jan 1;264:118627. doi: 10.1016/j.lfs.2020.118627. Epub 2020 Oct 22. Life Sci. 2021. PMID: 33169684 Review.
-
The Gut Microbiota and Alzheimer's Disease.J Alzheimers Dis. 2017;58(1):1-15. doi: 10.3233/JAD-161141. J Alzheimers Dis. 2017. PMID: 28372330 Review.
-
Invited Review: From nose to gut - the role of the microbiome in neurological disease.Neuropathol Appl Neurobiol. 2019 Apr;45(3):195-215. doi: 10.1111/nan.12520. Epub 2018 Dec 9. Neuropathol Appl Neurobiol. 2019. PMID: 30298527 Review.
Cited by
-
Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.J Mol Neurosci. 2021 Jul;71(7):1436-1455. doi: 10.1007/s12031-021-01829-3. Epub 2021 Apr 8. J Mol Neurosci. 2021. PMID: 33829390 Review.
-
Protective Effect of Anthocyanins against Neurodegenerative Diseases through the Microbial-Intestinal-Brain Axis: A Critical Review.Nutrients. 2023 Jan 18;15(3):496. doi: 10.3390/nu15030496. Nutrients. 2023. PMID: 36771208 Free PMC article. Review.
-
Association of perturbation of oral bacterial with incident of Alzheimer's disease: A pilot study.J Clin Lab Anal. 2022 Jul;36(7):e24483. doi: 10.1002/jcla.24483. Epub 2022 Jun 11. J Clin Lab Anal. 2022. PMID: 35689551 Free PMC article.
-
Gut Microbiota, Its Role in Induction of Alzheimer's Disease Pathology, and Possible Therapeutic Interventions: Special Focus on Anthocyanins.Cells. 2020 Apr 1;9(4):853. doi: 10.3390/cells9040853. Cells. 2020. PMID: 32244729 Free PMC article. Review.
-
Knock-on effect of periodontitis to the pathogenesis of Alzheimer's disease?Wien Klin Wochenschr. 2020 Sep;132(17-18):493-498. doi: 10.1007/s00508-020-01638-5. Epub 2020 Mar 25. Wien Klin Wochenschr. 2020. PMID: 32215721 Free PMC article.
References
-
- Lai KSP, Liu CS, Rau A, et al. 2017. Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies. J. Neurol. Neurosurg. Psychiatry 88: 876–882. - PubMed
-
- Schmidt R, Schmidt H, Curb JD, et al. 2002. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia aging study. Ann. Neurol 52: 168–174. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous